FDA rejects Immunomedics' filing seeking approval of sacituzumab govitecan in triple-negative breast cancer | FirstWord Pharma m.firstwordpharma.com/fda-rejects-im…

Fighting for their legacies is all they know. It's Game of Thrones meets #PlanetEarth2. #Dynasties premieres tomorrow at 9pm on @BBCAmerica.

Good news for George Herbert Walker Bush: As of today, he is no longer the biggest wimp ever to serve as President of the United States.

The most ridiculous call of 2019 (so far) A thread.

Making booster shots mandatory without powerful evidence of a community benefit could cost public trust just when it’s needed most bloomberg.com/opinion/articl… via bopinion

Approximately 80% of patients who underwent stem cell transplant & received #COVID19 vaccine remained above the threshold of an anti-receptor binding domain of 100U/ml or higher at 6 months. ja.ma/3vvTnKJ

Our CANINE study published yesterday in JAMA Oncology.

Thank you Paul for accurately summarizing our study. Some ‘anti-fear’ data indeed! JAMA Oncology

This week The Lancet's cover

First author publication by our fellow Dr Anthony Rooney with Qamar Khan on breakthrough COVID infections in vaccinated cancer patients! KU Cancer Center University of Kansas Graduate Medical Education KU Medical Center jhoonline.biomedcentral.com/articles/10.11…

#ASCO22 excellent NRG trial presentation. Good prognosis from oligometastatic breast cancer is a function of better biology not local therapy!

Martinez time please.

Honored to have been selected to present our work on molecular biomarkers of chemoimmunotherapy response in #tnbc in the #ASCO23 #breastcancer session. #bcsm

🚨 Qamar Khan X7/7 Study shows fixed dose cape has same PFS/OS, and lower toxicity in MBC. OncoAlert #ASCO23

#BREAKING: Harvard will not comply with the Trump administration’s demands to dismantle its diversity programming and limit student protests in exchange for federal funding, University President Alan Garber announced. Dhruv Patel & Grace Yoon report. thecrimson.com/article/2025/4…

“No government—regardless of which party is in power—should dictate what private universities can teach, whom they can admit and hire, and which areas of study and inquiry they can pursue.” - President Alan Garber hrvd.me/GarberRespond3…

ascopubs.org/doi/10.1200/JC… Oncology Brothers OncoAlert Journal of Clinical Oncology KU Cancer Center Zahra M, PharmD, MBA, BCOP, FHOPA

Regulatory agencies FDA Drug Information EU Medicines Agency and guidelines National Comprehensive Cancer Network (NCCN) must critically review data before approval of cancer drugs. Transparency in censoring practices should be required for publication in leading journals NEJM Journal of Clinical Oncology as The Lancet The Lancet Oncology do.

Regulatory agencies FDA Drug Information EU Medicines Agency and guidelines National Comprehensive Cancer Network (NCCN) must critically review data before approval of cancer drugs. Transparency in censoring practices should be required for publication in leading journals NEJM Journal of Clinical Oncology as The Lancet and The Lancet Oncology already do.

RIP WHI.